Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falko Fend

Showing results (281-290 of 399) with videos related to

Pageof 40
Sort By:
Communications Biology|December 30, 2025
Nanosecond pulsed electric fields induce cell-size-dependent selective permeabilization of urothelial cancer cellsAleksander Kielbik, Emily Hellwich, Veronika Bahlinger, et al.
Cancers|November 11, 2022
Recurrence Score<sup>®</sup> Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting-Results of the IRMA TrialDominik Dannehl, Tobias Engler, Lea L Volmer, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 1, 2013
SOX2 expression and prognostic significance in ovarian carcinomaDeborah L Pham, Veit Scheble, Petra Bareiss, et al.
Cancer Research|June 17, 2010
ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancerAnja Baumgart, Stefan Seidl, Petros Vlachou, et al.
Oncotarget|September 5, 2015
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytomaInes Leinhäuser, Andrea Richter, Misu Lee, et al.
Stem Cells Translational Medicine|January 4, 2013
Shared cell surface marker expression in mesenchymal stem cells and adult sarcomasStefan Wirths, Elke Malenke, Torsten Kluba, et al.
Human Gene Therapy|August 13, 2009
Therapeutic vaccination with an interleukin-2-interferon-gamma-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/II trialThomas H Brill, Hubert R Kübler, Heike Pohla, et al.
International Journal of Colorectal Disease|August 16, 2008
Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapyBjörn L D M Brücher, Gisela Keller, Martin Werner, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2011
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinomaPatrick L Wagner, Ann-Cathrin Stiedl, Theresia Wilbertz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 10, 2004
Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection systemArmando Gamboa-Dominguez, Claudia Dominguez-Fonseca, Leticia Quintanilla-Martinez, et al.
Pageof 40

Showing results (281-290 of 399) with videos related to

Sort By:
Pageof 40
Communications Biology|December 30, 2025
Nanosecond pulsed electric fields induce cell-size-dependent selective permeabilization of urothelial cancer cellsAleksander Kielbik, Emily Hellwich, Veronika Bahlinger, et al.
Cancers|November 11, 2022
Recurrence Score<sup>®</sup> Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting-Results of the IRMA TrialDominik Dannehl, Tobias Engler, Lea L Volmer, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 1, 2013
SOX2 expression and prognostic significance in ovarian carcinomaDeborah L Pham, Veit Scheble, Petra Bareiss, et al.
Cancer Research|June 17, 2010
ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancerAnja Baumgart, Stefan Seidl, Petros Vlachou, et al.
Oncotarget|September 5, 2015
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytomaInes Leinhäuser, Andrea Richter, Misu Lee, et al.
Stem Cells Translational Medicine|January 4, 2013
Shared cell surface marker expression in mesenchymal stem cells and adult sarcomasStefan Wirths, Elke Malenke, Torsten Kluba, et al.
Human Gene Therapy|August 13, 2009
Therapeutic vaccination with an interleukin-2-interferon-gamma-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/II trialThomas H Brill, Hubert R Kübler, Heike Pohla, et al.
International Journal of Colorectal Disease|August 16, 2008
Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapyBjörn L D M Brücher, Gisela Keller, Martin Werner, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2011
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinomaPatrick L Wagner, Ann-Cathrin Stiedl, Theresia Wilbertz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 10, 2004
Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection systemArmando Gamboa-Dominguez, Claudia Dominguez-Fonseca, Leticia Quintanilla-Martinez, et al.
Pageof 40